drugset / Trial / NCT04411212

G-CSF and PRP in Patients With Recurrent Implantation Failure

NCT04411212

RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this randomized controlled trial is to determine whether granulocyte colony-stimulating factor and platelet-rich plasma can be used to enhance the IVF-ET outcomes in patients with recurrent implantation failure

Timeline

Start
2020-05-28
Primary completion
2020-12-31
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Platelet Rich Plasma Other / unclassified 1 ml Other
Comparator filgrastim Protein / enzyme biologic 300 ug Subcutaneous

Indications